MELANOMA (SKIN CANCER)
Clinical trials for MELANOMA (SKIN CANCER) explained in plain language.
Never miss a new study
Get alerted when new MELANOMA (SKIN CANCER) trials appear
Sign up with your email to follow new studies for MELANOMA (SKIN CANCER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy trial opens for Tough-to-Treat cancers
Disease control Not yet recruitingThis early-stage study is testing a new cell-based treatment called SL-28 in adults with advanced solid tumors that have not responded to standard therapies. The main goals are to find the safest and most effective dose and to check for side effects. Participants will receive the…
Matched conditions: MELANOMA (SKIN CANCER)
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New program aims to guide young cancer survivors through critical Follow-Up care
Disease control Not yet recruitingThis study is creating and testing a patient navigation program to help young adults who have survived cancer. The program aims to guide survivors to get the recommended primary care and cancer check-ups they need. Researchers will first adapt an existing program for young surviv…
Matched conditions: MELANOMA (SKIN CANCER)
Phase: NA • Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Breakthrough scan could match cancer patients to best treatments
Diagnosis Not yet recruitingThis study is testing a new type of PET scan that detects a protein called PD-L1 in tumors. Researchers want to see if this scan can identify which patients with lung cancer, melanoma, or other solid tumors are most likely to benefit from immunotherapy drugs. The scan uses a radi…
Matched conditions: MELANOMA (SKIN CANCER)
Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC
-
Simple blood test could tell doctors which cancer patients will respond to immunotherapy
Diagnosis Not yet recruitingThis study aims to develop a blood test that predicts whether cancer patients will benefit from immunotherapy drugs. Researchers will analyze blood samples from 600 patients with lung cancer, melanoma, breast cancer, kidney cancer, or head/neck cancer before they start treatment.…
Matched conditions: MELANOMA (SKIN CANCER)
Sponsor: OncoHost Ltd. • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
Fitbits and smartphones could help cancer patients manage treatment side effects
Symptom relief Not yet recruitingThis study is testing whether a remote monitoring system using a Fitbit and weekly symptom surveys can help patients better manage side effects during cancer immunotherapy. Researchers want to see if this digital tool is easy for patients to use and if it improves their quality o…
Matched conditions: MELANOMA (SKIN CANCER)
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
New exercise plan aims to ease skin cancer surgery recovery
Symptom relief Not yet recruitingThis small pilot study is testing whether a structured exercise and education program helps people with melanoma recover better from surgery. The program includes sessions with a physiotherapist before and after the operation to build strength and manage symptoms. Researchers wil…
Matched conditions: MELANOMA (SKIN CANCER)
Phase: PHASE1 • Sponsor: McMaster University • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Scientists probe Fat's role in skin cancer spread
Knowledge-focused Not yet recruitingThis study aims to understand if a specific interaction between fat cells and immune cells in a melanoma tumor can predict whether the cancer will spread. Researchers will analyze old tissue samples from past melanoma patients to look for this pattern. The goal is to gain knowled…
Matched conditions: MELANOMA (SKIN CANCER)
Sponsor: The Christie NHS Foundation Trust • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Simple blood test could tell doctors if cancer treatment will work
Knowledge-focused Not yet recruitingThis study aims to see if a blood test can predict which patients with advanced lung cancer or melanoma will respond to a common type of immunotherapy. Researchers will analyze tiny particles in the blood of 378 patients before and during their standard treatment. The goal is to …
Matched conditions: MELANOMA (SKIN CANCER)
Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:08 UTC